🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates the safety, tolerability, maximum tolerated dose (MTD)...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-03-01
Trial ID
NCT07339839
Treatments Being Tested
To assess safety, tolerability, PK, efficacy and determine recommended phas...
Status
Active Not Recruiting
Location
Beijing Cancer Hospital
Start Date
2021-07-26
Trial ID
NCT05009329
The primary objective of this study is to determine the effect of food in h...
Status
Completed
Location
Beijing GoBroad Boren Hospital
Start Date
2023-05-12
Trial ID
NCT05875493
This study is to evaluate the safety, tolerability, pharmacokinetics and an...
Status
Active Not Recruiting
Location
Research site31
Start Date
2022-02-17
Trial ID
NCT05194995
Mass Balance Study of \[14C\]JAB-21822 in China Healthy Subjects...
Status
Completed
Location
The First Affiliated Hospital of Soochow University
Start Date
2023-07-08
Trial ID
NCT05920941
Treatments Being Tested
This is a multicenter, open-label phase 1/2a study consisting of two parts:...
Status
Recruiting
Location
The First Affiliated Hospital of USTC Anhui Provincial Hospital
Start Date
2022-04-14
Trial ID
NCT05288205
Evaluate the safety and tolerability, drug levels, and clinical activity of...
Status
Recruiting
Location
Research site08
Start Date
2022-08-17
Trial ID
NCT05276726
Treatments Being Tested
This Phase 3 study will evaluate the efficacy of JAB-21822+JAB-3312 versus ...
Status
Recruiting
Location
Anhui Province cancer hospital
Start Date
2024-08-07
Trial ID
NCT06416410
Treatments Being Tested
Patients with other advanced solid tumors (excluding NSCLC and CRC) who hav...
Status
Recruiting
Location
Anhui Provincial Cancer Hospital
Start Date
2023-10-27
Trial ID
NCT06008288
Treatments Being Tested
This is a phase I study to evaluate drug-drug interactions (DDIs) of JAB-21...
Status
Completed
Location
Beijing GoBroad Hospital
Start Date
2023-11-25
Trial ID
NCT06162169
Treatments Being Tested